Author:
Lu Chao,Kasagi Kanji,Hidaka Akinari,Hatabu Hiroto,Iida Yasuhiro,Konishi Junji
Abstract
Abstract.
A new and practical assay was developed using cultured FRTL-5 cells for simultaneous assessment of TS-ab and TSH-binding inhibitor immunoglobulin, allowing direct comparison of these two activities under the same conditions. Subsequent to the TS-ab assay in which extracellular cAMP concentration in Hanks' medium without NaCl was determined, [125I]bTSH in this medium was added to observe the ability of serum Ig to inhibit the binding of [125I]bTSH to FRTL-5 cells. We found a much higher specific binding of [125I]bTSH to FRTL-5 cells and a much greater inhibition of [125I]bTSH binding to the cells exposed to Graves' Ig in hypotonic NaCl-free than in NaCl containing Hanks' medium, indicating that the binding of both TSH and Graves' Ig to the TSH receptor was salt-sensitive. The inhibitory activity of [125I]bTSH binding to the cells was 0.2±4.6% (mean ±sd) in 45 normals. Inter-assay coefficients of variation in two positive controls with the mean values of 18.0 and 65.8% were 15.8 and 16.5%, respectively. Among 46 patients with untreated hyperthyroidism owing to Graves' disease, 45 (97.8%) were positive for TS-ab; 35 (76.1%) and 40 (87.0%) were positive for TSH-binding inhibitor in Ig assays using FRTL-5 cells and solubilized porcine thyroid membranes, respectively. TS-ab activities correlated less closely with TSH-binding inhibitory activities determined using FRTL-5 cells (r=0.576, p<0.001) than with those determined using porcine thyroid membranes (r=0.745, p<0.001). The correlation between TSH-binding inhibitory activities determined by the two methods, although statistically significant (r=0.537, p<0.001) was rather rough. Some patients clearly demonstrated discrepant results, suggesting the existence of heterogeneous populations of TSH receptor antibodies.
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献